SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-15-116094
Filing Date
2015-04-01
Accepted
2015-04-01 16:10:46
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d898728ds3.htm S-3 375459
2 EX-4.6 d898728dex46.htm EX-4.6 299619
3 EX-4.9 d898728dex49.htm EX-4.9 105715
4 EX-4.10 d898728dex410.htm EX-4.10 105206
5 EX-4.11 d898728dex411.htm EX-4.11 94704
6 EX-5.1 d898728dex51.htm EX-5.1 26959
7 EX-12.1 d898728dex121.htm EX-12.1 13951
8 EX-23.1 d898728dex231.htm EX-23.1 1803
9 GRAPHIC g898728g74d85.jpg GRAPHIC 5465
10 GRAPHIC g898728img001.jpg GRAPHIC 6907
  Complete submission text file 0001193125-15-116094.txt   1041871
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-203180 | Film No.: 15743435
SIC: 2834 Pharmaceutical Preparations